| Novel Compounds for the Treatment, Alleviation or Prevention of Disorders … |
2023-4-04 |
2023-8-17 |
|
| Heterologous Administration of Tau Vaccines |
2023-2-20 |
2023-8-17 |
|
| Humanized anti-tdp-43 binding molecules and uses thereof |
2023-2-16 |
2023-8-24 |
|
| Anti-alpha-synuclein therapeutic vaccines |
2023-2-09 |
2023-8-17 |
|
| Compositions of phosphorylated tau peptides and uses thereof |
2023-2-09 |
2023-5-23 |
|
| Dihydro-oxazol derivative compounds |
2022-12-22 |
2023-6-29 |
|
| Anti-tau antibodies and methods of use |
2022-12-08 |
2023-4-11 |
|
| Mimotopes of alpha-synuclein and vaccines thereof for the treatment of … |
2022-11-21 |
2023-6-29 |
|
| Novel molecules for therapy and diagnosis |
2022-11-16 |
2023-5-25 |
|
| Dihydropyrrolo[3,4-c]pyrazole derivatives and their use in diagnosis |
2022-11-10 |
2023-5-19 |
|
| Dihydropyrrolo[3,4c]-pyrazole derivatives and their use in diagnosis |
2022-11-10 |
2023-5-19 |
|
| 4h-imidazo[1,5-b]pyrazole derivatives for diagnosis |
2022-11-10 |
2023-5-19 |
|
| Method of safe administration of tau phosphopeptide conjugate |
2022-9-29 |
2023-4-06 |
|
| Liposomes containing phosphorylated tau peptides for inducing sustained immune … |
2022-8-12 |
2023-2-16 |
|
| 1,3,4,5-tetrahydro-2h-pyrido(4,3-b)indole derivatives for treatment, … |
2022-8-10 |
2022-11-15 |
|
| Anti-Tau antibodies and methods of use |
2022-7-25 |
2022-9-15 |
|
| Compounds for imaging tau protein aggregates |
2022-7-24 |
2022-9-01 |
|
| Novel compounds for the diagnosis of tdp-43 proteinopathies |
2022-7-15 |
2023-1-19 |
|
| Novel molecules for diagnosis |
2022-3-09 |
2022-5-01 |
|
| HUMANIZED ANTIBODIES AGAINST AMYLOID β |
2022-1-11 |
2022-5-13 |
|
| Antibody delivery |
2021-12-17 |
2023-7-27 |
|
| Anti-tdp-43 binding molecules and uses thereof |
2021-11-22 |
2022-1-01 |
|
| Anti-abeta vaccine therapy |
2021-11-21 |
2022-1-01 |
|
| Antibodies binding to alpha-synuclein for therapy and diagnosis |
2021-10-15 |
2023-8-23 |
|
| Novel compounds |
2021-10-11 |
2023-8-08 |
|
| Bicyclic compounds for diagnosis and therapy |
2021-8-25 |
2022-1-06 |
|
| HUMANIZED ANTI-TDP-43 BINDING MOLECULES AND THEIR USES |
2021-8-13 |
2022-11-16 |
|
| Immunogenic compounds |
2021-8-04 |
2022-2-10 |
|
| Humanized antibody |
2021-8-04 |
2022-7-21 |
|
| Method of safe administration of phosphorylated tau peptide vaccine |
2021-7-27 |
2021-9-30 |
|
| Dihydrooxazole and thiourea or urea derivatives modulating the nlrp3 … |
2021-6-18 |
2023-4-26 |
|
| COMPOUNDS FOR DIAGNOSIS |
2021-5-07 |
2022-12-13 |
|
| Dose treatment of tauopathies |
2021-3-18 |
2023-3-28 |
|
| Novel compounds for diagnosis |
2020-12-06 |
2021-1-31 |
|
| Novel molecules for therapy and diagnosis |
2020-12-04 |
2021-6-10 |
|
| Humanized antibody |
2020-11-16 |
2021-10-14 |
|
| Therapeutic anti-abeta vaccines |
2020-11-10 |
2021-1-29 |
|
| Anti-tau antibodies and methods of use |
2020-10-09 |
2021-5-13 |
|
| Microradioactive Binding Assays for Ligand Screening |
2020-9-30 |
2022-5-31 |
|
| HUMANIZED ANTIBODIES AGAINST AMYLOID β |
2020-7-22 |
2021-1-21 |
|
| New method to prepare compound for imaging |
2020-7-16 |
2020-10-30 |
|
| Diagnostic compositions for pet imaging, a method for manufacturing the … |
2020-7-12 |
2020-8-31 |
|
| Misfolded tdp-43 binding molecules |
2020-7-05 |
2020-8-31 |
|
| Fused 1, 2-thiazoles and 1, 2-thiazines as NLRP3 modulators |
2020-6-22 |
2022-2-01 |
|
| Disaccharide synthetic lipid compounds and uses thereof |
2020-5-26 |
2020-9-17 |
|
| ANTI-TDP-43 BINDING MOLECULES AND USES THEREOF |
2020-5-22 |
2021-11-17 |
|
| MOLECULES FOR THERAPY AND DIAGNOSIS |
2020-4-24 |
2021-11-03 |
|
| Novel molecules for therapy and diagnosis |
2020-4-20 |
2021-2-01 |
|
| Humanized antibody |
2020-4-08 |
2009-3-27 |
|
| Novel compounds for the treatment, alleviation or prevention of disorders … |
2020-2-20 |
2021-1-01 |
|
| METHOD OF SAFE ADMINISTRATION OF PHOSPHORYLATED TAU PEPTIDE VACCINE |
2020-2-07 |
2021-10-05 |
|
| Novel compounds for the treatment, alleviation or prevention of disorders … |
2020-1-09 |
2020-5-14 |
|
| Tetrahydrobenzofuro[2,3-c]pyridine and beta-carboline compounds for the … |
2019-5-30 |
2023-8-29 |
2023-8-29 |
| Novel compounds for the treatment, alleviation or prevention of disorders … |
2019-5-20 |
2021-4-14 |
|
| Anti-abeta therapeutic vaccine |
2019-4-09 |
2021-1-01 |
|
| THERAPEUTIC ANTI-Ab VACCINES |
2019-4-09 |
2020-10-14 |
|
| COMPOUNDS FOR THE TREATMENT, RELIEF OR PREVENTION OF DISORDERS ASSOCIATED WITH … |
2019-3-08 |
2021-8-18 |
|
| Azacarboline compounds for the detection of tau aggregates |
2019-1-22 |
2019-8-01 |
|
| Gamma-carboline compounds for the detection of Tau aggregates |
2019-1-22 |
2022-4-19 |
2022-4-19 |
| HUMANIZED ANTIBODY |
2018-8-21 |
2020-1-15 |
|
| Humanized antibody against amyloid beta |
2018-7-03 |
2018-7-19 |
|
| Humanized antibody igg1 |
2018-2-22 |
2019-1-31 |
|
| HUMANIZED ANTIBODIES AGAINST AMYLOID β |
2017-12-20 |
2018-6-21 |
|
| Anti-tau antibodies and methods of use |
2017-12-06 |
2022-12-23 |
|
| Compounds for imaging tau protein aggregates |
2017-7-21 |
2018-1-25 |
|
| Pharmaceutical composition |
2017-5-23 |
2017-12-22 |
|
| Aβ1-42 SPECIFIC MONOCLONAL ANTIBODIES HAVING THERAPEUTIC PROPERTIES |
2017-3-31 |
2017-9-07 |
|
| Bicyclic compounds for diagnosis and therapy |
2017-3-10 |
2022-3-25 |
|
| Pharmaceutical composition |
2017-1-20 |
2017-6-29 |
|
| MONOCLONAL ANTIBODY AFTER INCUBATION WITH MONOMERIC PEPTIDES Ab 1-42 INHIBITES … |
2017-1-12 |
2018-4-18 |
|
| Method for vaccination against a self-antigen in a human patient |
2016-11-02 |
2018-5-10 |
|
| Phosphospecific antibodies recognising tau |
2016-10-28 |
2017-5-18 |
|
| SAFE AND FUNCTIONAL HUMANIZED ANTI β-AMYLOID ANTIBODY |
2016-9-12 |
2017-3-16 |
|
| Novel imaging compounds |
2016-7-15 |
2018-9-20 |
|
| Disaccharide synthetic lipid compounds and uses thereof |
2016-6-07 |
2017-12-07 |
|
| Anti-tau antibodies and methods of use tau |
2016-5-30 |
2017-2-03 |
|
| Phosphospecific antibodies recognising tau |
2016-4-13 |
2016-6-16 |
|
| Humanized Antibody |
2015-12-22 |
2016-8-25 |
|
| Novel Compounds for the Treatment of Diseases Associated with Amyloid or … |
2015-11-02 |
2016-6-09 |
|
| Humanized tau antibody tau |
2015-10-06 |
2016-3-24 |
|
| Monoclonal Antibody |
2015-9-22 |
2016-1-07 |
|
| Dihydropyridopyrrole derivatives as tau-pet-ligands |
2015-7-15 |
2017-1-18 |
|
| Method for therapeutic use |
2015-7-06 |
2015-12-10 |
|
| Methods and compositions comprising supramolecular constructs |
2015-6-08 |
2015-7-03 |
|
| A beta 1-42 specific monoclonal antibodies with therapeutic properties |
2015-4-08 |
2015-4-30 |
|
| Use of anti-amyloid beta antibody in ocular diseases |
2015-2-19 |
2016-12-15 |
2016-12-15 |
| Use of anti-amyloid beta antibody in ocular diseases |
2015-2-06 |
2016-10-27 |
2016-10-27 |
| Carbazole and carboline compounds for use in the diagnosis, treatment, … |
2015-1-21 |
2020-5-26 |
2020-5-26 |
| Antibodies obtainable using supramolecular constructs |
2014-11-26 |
2018-5-22 |
2018-5-22 |
| 2,6-Diaminopyridine Compounds Suitable for Treating Diseases Associated with … |
2014-9-30 |
2015-1-22 |
|
| Vaccine therapy |
2014-3-20 |
2017-8-30 |
|
| Método de administração segura de vacina de peptídeo de tau fosforilada |
2020-2-07 |
2021-10-05 |
|
| Composes de tetrahydrobenzofuro[2,3-c]pyridine et de beta-carboline pour le … |
2019-5-30 |
2023-8-29 |
2023-8-29 |